Antiproliferative Activity of Microsclerodermins


The subject invention pertains to a series of cyclic peptides known as the microsclerodermins, which possess unusual amino acids, and which have been observed to inhibit the proliferation of tumor cell lines. The subject invention also pertains to methods useful in inhibiting pathological cellular proliferation in animals, including humans and other mammals. In accordance with the teachings of the subject invention, microsclerodermin compounds can be used to inhibit cellular proliferation including that which is responsible for tumors and other cancers. In a specific embodiment, the novel compositions and methods of use of the subject invention can advantageously be useful in the treatment of a patient hosting cancer cells, for example, inhibiting the growth of tumor cells in a mammalian host.

Patent Information:
Drug Discovery
For Information, Contact:
Dana Vouglitois
Florida Atlantic University
Ricahrd Isbrucker
Ross Longley
Amy Wright
Shirley Pomponi
© 2017. All Rights Reserved. Powered by Inteum